Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2012
10/31/2012EP2516417A1 Isoindolinone inhibitors of phosphatidylinositol 3-kinase
10/31/2012EP2515656A1 Aminobenzoquinazolinone m1 receptor positive allosteric modulators
10/31/2012EP2515655A1 1h-pyrazolo[3,4-beta]pyridines and therapeutic uses thereof
10/31/2012CN102762567A Diaza-spiro[5.5]undecanes as orexin receptor antagonists
10/31/2012CN102762566A Photoconductive sensor materials for detection of explosive vapor
10/31/2012CN102762565A Pyrido[3,2-d]pyrimidine PI3[delta] inhibitor compounds and methods of use
10/31/2012CN102762564A Ghrelin receptor agonist for treatment of dyscrasia
10/31/2012CN102762563A Pyrazolo piperidine derivatives as nadph oxidase inhibitors
10/31/2012CN102762562A Pyrazolo piperidine derivatives as nadph oxidase inhibitors
10/31/2012CN102762561A Gamma secretase modulaters
10/31/2012CN102762560A Disubstituted heteroaryl-fused pyridines
10/31/2012CN102762559A Diphenyl-pyrazolopyrdine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators
10/31/2012CN102762558A Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
10/31/2012CN102762557A Triazolopyridines
10/31/2012CN102762556A Imidazo[1,2-a] pyridine compounds, synthesis thereof, and methods of using same
10/31/2012CN102762555A Fluorescent cellular markers
10/31/2012CN102762548A Isoindolinone inhibitors of phosphatidylinositol 3-kinase
10/31/2012CN102762546A Materials for organic light emitting devices
10/31/2012CN102757429A Process for producing acehytisine hydrochloride by biologically converting aconitum coreanum hair root
10/31/2012CN102757428A Preparation method of enoxacin gluconate
10/31/2012CN102757422A Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H- indazole-3-carboxamide and their therapeutic uses as p2y12 antagonists
10/31/2012CN102757300A Benzophenanthrene derivative, preparation method and light emitting device made thereof
10/31/2012CN102755320A Medicine composition and healthcare food for treating arthritis
10/31/2012CN101962382B Symmetric nickel naphthotriazine complex and application thereof
10/31/2012CN101454297B Aryl-4-ethynyl-isoxazole derivatives
10/31/2012CN101356173B Novel pyridopyrazines and their use as modulators of kinases
10/30/2012US8299354 Luminescent solar collector
10/30/2012US8299252 Pyrazolopyridine and pyrrolopyridine multikinase inhibitors
10/30/2012US8299248 Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
10/30/2012US8299058 Spiro-condensed indoline derivatives as pesticides
10/30/2012US8299056 Aminotriazolopyridines, compositions thereof, and methods of treatment therewith
10/30/2012US8298512 Methods of determining β-III tubulin expression
10/30/2012CA2682504C Aurora kinase modulators and method of use
10/30/2012CA2548156C Amine derivatives
10/30/2012CA2536136C Aryloxy and arylalkyleneoxy substituted imidazoquinolines
10/26/2012WO2012145173A1 Substituted oligoazacarbazoles for light emitting diodes
10/26/2012WO2012144463A1 Therapeutic agent for tumor
10/26/2012WO2012144421A1 NOVEL COMPOUND HAVING α-CYANOACRYLATE STRUCTURE, DYE, AND COLORING PHOTOSENSITIVE COMPOSITION
10/26/2012WO2012143813A1 Pyrazolospiroketone derivatives for use as acetyl - coa carboxylase inhibitors
10/26/2012WO2012143801A1 Manufacturing process for tadalafil from racemic or l-tryptophan
10/26/2012WO2012143726A1 Bicyclic heterocycle compounds and their uses in therapy
10/26/2012WO2012143725A1 Bicyclic heterocycle compounds and their uses in therapy
10/26/2012WO2012143599A1 Androgen receptor modulating carboxamides
10/26/2012WO2012143416A2 Novel compounds
10/26/2012WO2012143329A1 Triazolopyridines
10/26/2012WO2012143143A1 Heterocyclic compounds as kinase inhibitors
10/26/2012WO2012143080A2 Materials for organic electroluminescent devices
10/26/2012WO2012088038A3 Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
10/26/2012WO2011113606A8 Anti-infective compounds
10/26/2012WO2011085990A8 Anti - infective pyrido (1,2 -a) pyrimidines
10/26/2012CA2833657A1 Triazolopyridines
10/26/2012CA2831680A1 Heterocyclic compounds as kinase inhibitors
10/26/2012CA2831380A1 Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors
10/26/2012CA2831346A1 Bicyclic heterocycle compounds and their uses in therapy
10/26/2012CA2831338A1 Androgen receptor modulating carboxamides
10/26/2012CA2828946A1 Therapeutic agent for tumor
10/25/2012US20120271053 Novel compound having affinity for amyloid
10/25/2012US20120270897 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
10/25/2012US20120270893 Substituted acetyl-coa carboxylase inhibitors
10/25/2012US20120270879 Heterocyclic Compounds As CCR1 Receptor Antagonists
10/25/2012US20120270871 Pyrrolopyridinylpyrimidin-2-ylamine derivatives
10/25/2012US20120270870 Indazole and Pyrazolopyridine Compounds As CCR1 Receptor Antagonists
10/25/2012US20120270867 Novel (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
10/25/2012US20120270866 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
10/25/2012US20120270863 Fused ring analogues of anti-fibrotic agents
10/25/2012US20120270858 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
10/25/2012US20120270853 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
10/25/2012US20120270838 Spiroimidazolone derivative
10/25/2012US20120270141 Nitrogen-containing aromatic compounds and metal complexes
10/25/2012US20120269831 Substituted pyrido[2,3-d]pyrimidin-7(8h)-ones and therapeutic uses thereof
10/25/2012US20120269766 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
10/25/2012US20120267613 Organic light-emitting device
10/25/2012US20120267583 Stable free radical chromophores, processes for preparing the same, nonlinear optic materials and uses thereof in nonlinear optical applications
10/25/2012DE112010004065T5 Verfahren zur Erhöhung der Löslichkeit einer Transkriptaseinhibitor-Zusammensetzung A method for increasing the solubility of a composition transcriptase
10/25/2012DE102011007891A1 New ring-fused 4-aminopyrimidine compounds are guanylate cyclase stimulators useful to treat and/or prevent e.g. heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, vascular disease and renal insufficiency
10/25/2012DE102011007890A1 New fluoroalkyl-substituted pyrazolopyridine compounds are soluble guanylate cyclase stimulators, useful to treat e.g. heart disease, angina pectoris, hypertension, pulmonary hypertension, ischemia, vascular disease or renal insufficiency
10/24/2012EP2514751A1 Azaindazoles useful as inhibitor of kinases
10/24/2012EP2513111A1 Mk2 inhibitors
10/24/2012EP2513110A1 1, 7 - diazacarbazoles and their use in the treatment of cancer
10/24/2012EP2513109A1 Heterocyclic compounds and their uses
10/24/2012EP2513108A1 Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alcanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
10/24/2012EP2513107A1 Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors
10/24/2012EP2513106A1 Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors
10/24/2012EP2513105A1 2-arylimidazole derivatives as pde10a enzyme inhibitors
10/24/2012EP2513104A1 Anti parasitic dihydroazole compounds and compositions comprising same
10/24/2012EP2513103A1 Azaindole glucokinase activators
10/24/2012EP2513102A1 Ethynyl derivatives
10/24/2012EP2513101A1 Novel solvates of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate
10/24/2012EP2513100A1 New phenylhydrazone derivatives and their use as pharmaceuticals
10/24/2012EP2513089A1 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
10/24/2012EP2513059A1 Inhibitors of akt activity
10/24/2012EP2512524A1 Manganese chelates and their use as contrast agents in magnetic resonance imaging (mri)
10/24/2012EP2512250A1 Substituted pyrido[2,3-d]pyrimidin-7(8h)-ones and therapeutic uses thereof
10/24/2012EP2512246A1 Aminopyrimidines as syk inhibitors
10/24/2012EP2512245A1 Pyridoquinazolinone m1 receptor positive allosteric modulators
10/24/2012CN102753552A Novel benzoic pyrrolopyridine derivatives
10/24/2012CN102753551A 2-arylimidazole derivatives as pde10a enzyme inhibitors
10/24/2012CN102753550A Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors
10/24/2012CN102753549A Compounds and methods for kinase modulation, and indications therefor
10/24/2012CN102753548A Fused heteroaromatic pyrrolidinones
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 646